{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:01:33Z","timestamp":1791558093555,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.metabol.2013.06.008","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T12:12:32Z","timestamp":1376568752000},"page":"1623-1632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes"],"prefix":"10.1016","volume":"62","author":[{"given":"Timothy J.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin N.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Ertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Krasinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay P.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Dairaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trageen","family":"Baumgart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Berahovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Schall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Jaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.metabol.2013.06.008_bb0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.metabol.2013.06.008_bb0010","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI20514","article-title":"Obesity-induced inflammatory changes in adipose tissue","volume":"112","author":"Wellen","year":"2003","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.metabol.2013.06.008_bb0015","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.2337\/db11-0194","article-title":"Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance","volume":"60","author":"Lee","year":"2011","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.metabol.2013.06.008_bb0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrendo.2009.62","article-title":"The role of interleukins in insulin resistance and type 2 diabetes mellitus","volume":"5","author":"Feve","year":"2009","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"10.1016\/j.metabol.2013.06.008_bb0025","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.2337\/db06-1650","article-title":"Increased number of islet-associated macrophages in type 2 diabetes","volume":"56","author":"Ehses","year":"2007","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.metabol.2013.06.008_bb0030","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/db10-0650","article-title":"Selective inactivation of c-jun nh2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice","volume":"60","author":"Zhang","year":"2011","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.metabol.2013.06.008_bb0035","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1007\/s00125-011-2248-8","article-title":"Critical role of chemokine (C-C motif) receptor 2 (CCR2) in the KKAy + Apoe \u2212\/\u2212 mouse model of the metabolic syndrome","volume":"54","author":"Martinez","year":"2011","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.metabol.2013.06.008_bb0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1758-5996-3-29","article-title":"The macrophage at the intersection of immunity and metabolism in obesity","volume":"3","author":"Samaan","year":"2011","journal-title":"Diabetology & metabolic syndrome"},{"issue":"2","key":"10.1016\/j.metabol.2013.06.008_bb0045","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2337\/db11-0860","article-title":"Increased macrophage migration into adipose tissue in obese mice","volume":"61","author":"Oh","year":"2012","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.metabol.2013.06.008_bb0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm.2627","article-title":"The cellular and signaling networks linking the immune system and metabolism in disease","volume":"18","author":"Osborn","year":"2012","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.metabol.2013.06.008_bb0055","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.metabol.2013.06.008_bb0060","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/diabetes.54.8.2277","article-title":"Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss","volume":"54","author":"Cancello","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.metabol.2013.06.008_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.metabol.2013.06.008_bb0070","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.metabol.2013.06.008_bb0075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/sj.ijo.0802839","article-title":"Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects","volume":"29","author":"Christiansen","year":"2005","journal-title":"Int J Obes"},{"issue":"4","key":"10.1016\/j.metabol.2013.06.008_bb0080","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2796.2007.01852.x","article-title":"Obesity-induced inflammation: a metabolic dialogue in the language of inflammation","volume":"262","author":"Ferrante","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2013.06.008_bb0085","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0083-6729(08)00621-3","article-title":"Interleukin-6 and insulin resistance","volume":"80","author":"Kim","year":"2009","journal-title":"Vitam Horm"},{"issue":"17","key":"10.1016\/j.metabol.2013.06.008_bb0090","doi-asserted-by":"crossref","first-page":"17070","DOI":"10.1074\/jbc.M312021200","article-title":"Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappab kinase in a p38 mapk-dependent manner","volume":"279","author":"de Alvaro","year":"2004","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.metabol.2013.06.008_bb0095","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1073\/pnas.1133870100","article-title":"Monocyte chemoattractant protein 1 in obesity and insulin resistance","volume":"100","author":"Sartipy","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.metabol.2013.06.008_bb0100","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1210\/en.2005-0969","article-title":"Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle","volume":"147","author":"Sell","year":"2006","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.metabol.2013.06.008_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0029-1241834","article-title":"Tnf-alpha inhibits insulin action in liver and adipose tissue: a model of metabolic syndrome","volume":"42","author":"Solomon","year":"2010","journal-title":"Horm Metab Res"},{"issue":"9","key":"10.1016\/j.metabol.2013.06.008_bb0110","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1172\/JCI34260","article-title":"Insulin sensitivity: modulation by nutrients and inflammation","volume":"118","author":"Schenk","year":"2008","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.metabol.2013.06.008_bb0115","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2013.06.008_bb0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.pharmtox.48.121806.154841","article-title":"Chemokines and their receptors: drug targets in immunity and inflammation","volume":"48","author":"Viola","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.metabol.2013.06.008_bb0125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MOL.0b013e3283393867","article-title":"Adipose tissue recruitment of leukocytes","volume":"21","author":"Anderson","year":"2010","journal-title":"Curr Opin Lipidol"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2013.06.008_bb0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.vph.2009.12.004","article-title":"The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue","volume":"52","author":"Surmi","year":"2010","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"10.1016\/j.metabol.2013.06.008_bb0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI27280","article-title":"Inflamed fat: what starts the fire?","volume":"116","author":"Neels","year":"2006","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.metabol.2013.06.008_bb0140","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/db09-1403","article-title":"C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis","volume":"59","author":"Obstfeld","year":"2010","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.metabol.2013.06.008_bb0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI24335","article-title":"Ccr2 modulates inflammatory and metabolic effects of high-fat feeding","volume":"116","author":"Weisberg","year":"2006","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.metabol.2013.06.008_bb0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5551\/jat.3368","article-title":"C-C chemokine receptor 2 inhibitor improves diet-induced development of insulin resistance and hepatic steatosis in mice","volume":"17","author":"Tamura","year":"2010","journal-title":"J Atheroscler Thromb"},{"issue":"12","key":"10.1016\/j.metabol.2013.06.008_bb0155","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1161\/ATVBAHA.108.168633","article-title":"Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db\/db mice","volume":"28","author":"Tamura","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.metabol.2013.06.008_bb0160","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/ki.2010.263","article-title":"CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice","volume":"78","author":"Kang","year":"2010","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.metabol.2013.06.008_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-6156.1000225","article-title":"Orally-administered chemokine receptor CCR2 antagonist CCX140-b in type 2 diabetes: a pilot double-blind, randomized clinical trial","volume":"3","author":"Hanefeld","year":"2012","journal-title":"J Diabetes Metab"},{"issue":"Supplement 1","key":"10.1016\/j.metabol.2013.06.008_bb0170","first-page":"S365","article-title":"Inhibition of the CCR2 chemokine receptor in diabetic mice results in a rapid and robust improvement of hyperglycemia","volume":"54","author":"Jaen","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2013.06.008_bb0175","unstructured":"Basak A, Charvat TT, Chen W, et al. Heteroaryl sulfonamides and CCR2. PCT Pat. Appl. WO2008008431 2008-01-07."},{"issue":"1","key":"10.1016\/j.metabol.2013.06.008_bb0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1124\/jpet.110.169714","article-title":"Characterization of CCX282-b, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease","volume":"335","author":"Walters","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.metabol.2013.06.008_bb0185","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI119798","article-title":"Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in c-c chemokine receptor 2 knockout mice","volume":"100","author":"Boring","year":"1997","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.metabol.2013.06.008_bb0190","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.metabol.2013.06.008_bb0195","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"issue":"2","key":"10.1016\/j.metabol.2013.06.008_bb0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0009-8981(67)90119-2","article-title":"Glucose-6-phosphatase assay on microgram amounts of liver tissue","volume":"17","author":"Ockerman","year":"1967","journal-title":"Clin Chim Acta"},{"issue":"Pt 12","key":"10.1016\/j.metabol.2013.06.008_bb0205","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1113\/jphysiol.2009.183996","article-title":"Acute exercise reduces hepatic glucose production through inhibition of the FOXO1\/HNF-4alpha pathway in insulin resistant mice","volume":"588","author":"De Souza","year":"2010","journal-title":"J Physiol"},{"issue":"10","key":"10.1016\/j.metabol.2013.06.008_bb0210","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1258\/ebm.2011.011105","article-title":"Solidago chilensis meyen hydroalcoholic extract reduces JNK\/IkappaB pathway activation and ameliorates insulin resistance in diet-induced obesity mice","volume":"236","author":"Melo","year":"2011","journal-title":"Exp Biol Med"},{"issue":"4","key":"10.1016\/j.metabol.2013.06.008_bb0215","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor fxr improves hyperglycemia and hyperlipidemia in diabetic mice","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6865","key":"10.1016\/j.metabol.2013.06.008_bb0220","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513001893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513001893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:03:18Z","timestamp":1758427398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049513001893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0026049513001893"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2013.06.008","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2013.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}